Let’s start up with the current stock price of Xenetic Biosciences Inc. (XBIO), which is $4.07 to be very precise. The Stock rose vividly during the last session to $4.97 after opening rate of $4.46 while the lowest price it went was recorded $3.82 before closing at $5.30.Recently in News on July 28, 2021, Xenetic Biosciences, Inc. Announces Closing of $12.5 Million Private Placement Priced at a Premium to Market. Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, today announced the closing of its previously announced private placement with a single healthcare-focused institutional investor for 4,629,630 shares of its common stock (or common stock equivalents) at a purchase price per share of $2.70, priced at-the-market under Nasdaq rules. The gross proceeds to Xenetic totaled approximately $12.5 million before deducting placement agent fees and other offering expenses. You can read further details here
Xenetic Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.36 on 07/29/21, with the lowest value was $1.50 for the same time period, recorded on 05/13/21.
Xenetic Biosciences Inc. (XBIO) full year performance was 247.86%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Xenetic Biosciences Inc. shares are logging -30.43% during the 52-week period from high price, and 435.53% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.76 and $5.85.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 18225769 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Xenetic Biosciences Inc. (XBIO) recorded performance in the market was 99.51%, having the revenues showcasing 107.65% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 46.40M, as it employees total of 4 workers.
The Analysts eye on Xenetic Biosciences Inc. (XBIO)
During the last month, 0 analysts gave the Xenetic Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.16, with a change in the price was noted +1.75. In a similar fashion, Xenetic Biosciences Inc. posted a movement of +75.43% for the period of last 100 days, recording 5,513,716 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for XBIO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Xenetic Biosciences Inc. (XBIO)
Raw Stochastic average of Xenetic Biosciences Inc. in the period of last 50 days is set at 65.23%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 65.23%. In the last 20 days, the company’s Stochastic %K was 71.31% and its Stochastic %D was recorded 61.73%.
Considering, the past performance of Xenetic Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 99.51%. Additionally, trading for the stock in the period of the last six months notably improved by 71.73%, alongside a boost of 247.86% for the period of the last 12 months. The shares increased approximately by 61.51% in the 7-day charts and went down by 99.51% in the period of the last 30 days. Common stock shares were driven by 107.65% during last recorded quarter.